This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Literature retrieved using the above keywords and published were included with a time limit from 1st January 2020 to 8th Aug 2024.ResultsThe ResultsThe bibliometric analysis of COVID-19 and Sudden Cardiac Death highlights key research trends from 2020 to 2024, revealing a rapid surge in scientific output during the pandemic.
Nature Reviews Cardiology, Published online: 02 January 2024; doi:10.1038/s41569-023-00962-3 Cardiovascular autonomic dysfunction (CVAD) is a malfunction of the autonomic control of circulatory homeostasis and is an important component of post-COVID-19 syndrome.
Getty Images milla1cf Wed, 03/20/2024 - 19:16 March 20, 2024 — SARS-CoV-2 , the virus that causes COVID-19 , can damage the heart even without directly infecting the heart tissue, a National Institutes of Health -supported study has found.
The cumulative incidence of MACE and all- cause of mortality in COVID-19 and non-COVID-19 pneumonia groups. The results indicate a lower risk of cardiovascular disease in COVID-19 patients. The results indicate a lower risk of cardiovascular disease in COVID-19 patients.
Out-of-hospital cardiac arrest survival rates dropped significantly at the onset of the COVID-19 pandemic in 2020 and have continued to remain lower than in the pre-pandemic years of 2015–2019, according to a preliminary study to be presented at the American Heart Association's Scientific Sessions 2024.,
Members of the National Academies of Sciences, Engineering, and Medicine describe the process and rationale for the development of the 2024 definition of persistent Covid-19 symptoms (long Covid).
Cardiovascular diseases (CVDs) have been reported to occur in a significant number of patients diagnosed with coronavirus disease 2019 (COVID-19). We report our experience regarding the occurrence of symptomatic and asymptomatic CVDs in COVID-19 patients. In this cross-sectional study, 690 COVID-19 patients were included.
Stroke, Volume 55, Issue 1 , Page 78-88, January 1, 2024. BACKGROUND:The association of COVID-19 with higher bleeding risk and worse outcomes in acute ischemic stroke (AIS) undergoing revascularization may be related to the presence of infection symptoms. 1.51]; S-COVID, 2.10 [95% CI, 1.75–2.53]). 2.32], respectively).
Stroke, Volume 55, Issue Suppl_1 , Page ATP34-ATP34, February 1, 2024. Background:Hemorrhagic cerebrovascular manifestations are known to be associated with COVID-19. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed. revealing an increase from pre-COVID 3.3
Circulation, Volume 150, Issue Suppl_1 , Page ASa907-ASa907, November 12, 2024. However, no large-scale studies have examined the impact of COVID-19 pandemic after EMS-witnessed OHCA, focusing on favorable neurological outcomes.Research Questions:Does COVID-19 pandemic affect favorable neurological outcomes after EMS-witnessed OHCA?Aims:To
In this review of dermatology news in April, we highlighted several major stories on such topics as cutaneous reactions to COVID-19, topical versus oral minoxidil, and FDA news.
Stroke, Volume 55, Issue Suppl_1 , Page ATP180-ATP180, February 1, 2024. Background:Coronavirus disease 2019 (COVID-19) increases the risk of cerebral venous sinus thrombosis (CVST), and previous reports derived from small case series reported a high mortality in these patients, up to 40%.
Circulation, Volume 150, Issue Suppl_1 , Page A4148010-A4148010, November 12, 2024. Background:Severe COVID-19 infection has been associated with acute respiratory distress syndrome (ARDS) and right ventricular (RV) dysfunction. Echocardiograms (echo) were obtained pre-cannulation, during ECMO, and post-ECMO decannulation.
Circulation, Volume 150, Issue Suppl_1 , Page A4114220-A4114220, November 12, 2024. Background:It is still not well understood whether cardiac injury observed during acute COVID-19 infection extends after recovery from the initial viral infection. Adult patients were identified by hospitalizations using ICD-10 code U07.1
Stroke, Volume 55, Issue Suppl_1 , Page AWP260-AWP260, February 1, 2024. Adult patients in 2018 (n=6,051,974) were compared to those in 2020 (n=5,470,813), the first year of the COVID-19 pandemic. To prevent potential confounding by undiagnosed COVID-19, patients in 2019 were not utilized in the analysis.
International Stroke Conference 2024 to Present High-Profile Late-Breaking Science 6. Chung-Ang University Study Looks at Cardiovascular Risks in COVID-19 Survivors 8. Penumbra Launches Indigo System CAT RX Catheter in Europe to Address Acute Coronary Syndrome 4. In Memoriam: Bruce Wilkoff, MD, FHRS 5.
Stroke, Volume 55, Issue Suppl_1 , Page AWP324-AWP324, February 1, 2024. COVID-19 neurological complications such as strokes and cognitive impairment have been reported. A mild and reproducible thromboembolic model will be a helpful tool for investigating COVID-thromboembolic complications.
Stroke, Volume 55, Issue Suppl_1 , Page A112-A112, February 1, 2024. We defined the COVID-19 pandemic epoch as 1/2020-1/2022. Introduction:The Vascular effects of Infection in Pediatric Stroke (VIPS II) study aimed to confirm prior findings that viral infection can trigger childhood arterial ischemic stroke (AIS).
Stroke, Volume 55, Issue Suppl_1 , Page A58-A58, February 1, 2024. Multivariable logistic models were used to evaluate the differences in mortality between patients admitted from April to December 2020, with and without COVID-19, and those admitted during a similar period in 2019. 2.51; SAH: 2.76, 1.68-4.54), 4.16; SAH: 5.77, 1.57-21.17).
The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of the Division of Cardiology at UCLA, effective July 1, 2024. Hsue will come to UCLA from UC San Francisco (UCSF), where she leads a portfolio of clinical and translational studies on HIV-related cardiovascular disease and Long COVID.
Publication date: Available online 23 February 2024 Source: The American Journal of Cardiology Author(s): Satyam Krishan, Khawaja Hassan Akhtar, Siddharth Agarwal, Jehanzeb Khan, Usman Baber
The COVID-19 pandemic highlighted the potential of video consults (VCs), even among older patients, to support self-care, improve disease management, and facilitate collaboration with caregivers. ESC Heart Failure 2024; 11 : 560–569. The results of this trial are eagerly anticipated. Original article: Man JP et al.
Circulation, Volume 149, Issue 9 , Page 707-716, February 27, 2024. The effectiveness of mRNA-based vaccines in the recent COVID-19 pandemic has undoubtedly proven the benefits of an RNA-based approach. RNA therapeutics hold significant promise in the treatment of cardiovascular diseases.
People who live in rural areas are dying from cardiovascular disease at a much greater rate than those living in urban areas, according to a report presented at AHA 2024 and simultaneously published in JACC. The report shows that disparities in mortality are greater among younger adults and was more pronounced during the COVID-19 pandemic.
I do not think that anyone can write about Covid without first recognising that the facts, may not actually be the facts. There was certainly a rapid drop during Covid. In the world of Covid research, two camps emerged very rapidly. I believe that Covid became one such area very quickly. Off with his head.
During the COVID-19 pandemic, the American Heart Association created a new 2024 Impact Goal with health equity at its core, in recognition of the increasing health disparities in our country and the overwhelming evidence of the damaging effect of structural racism on cardiovascular and stroke health. Circulation, Ahead of Print.
Italy is pioneering a push for telemedicine and home care in cardiology with the application of groundbreaking new regulation that took effect in January 2024. The system is decentralized with 19 regions and two autonomous provinces responsible for the delivery of health services through Local Health Units (ASLs).
Publication date: Available online 14 July 2024 Source: The American Journal of Cardiology Author(s): Shan-Shan Ji, Li-Xuan Zhao, Weiqiang Chen, Yi-Fan Wang, Fang-Chun Liu, Hai-Peng Li, Guo-Wei He, Jian Zhang
Publication date: Available online 11 March 2024 Source: The American Journal of Cardiology Author(s): Jasninder Singh Dhaliwal, Nomesh Kumar, Sebastian Mactaggart, Hemamalini Sakthivel, Raheel Ahmed, Renuka Verma, Kamleshun Ramphul
Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing serious COVID-19-related events and improving heart failure (HF) symptoms, according to six new substudies published in JACC.
In addition, the COVID-19 pandemic might have amplified the surgical risk. Although we primarily tested for non-inferiority, the magnitude of the difference surprised us,” Seiffert said. Valve prosthesis selection based on individual patients’ anatomical and medical considerations may have played a role.
Getty Images milla1cf Tue, 04/30/2024 - 12:56 April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center ( VUMC ) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure , a leading cause of hospitalization and death.
Data was unavailable for the remaining 34 participants mainly due to the COVID-19 pandemic. The meeting will be held in Phoenix, Feb. 7-9, and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health. This analysis found: At one-year, upper limb function improved by 5.3
Stroke, Volume 55, Issue Suppl_1 , Page AWMP60-AWMP60, February 1, 2024. However, limited information exists on how demographic and clinical factors are associated with social inequities among older patients hospitalized with acute ischemic stroke (AIS) during COVID-19.Methods:We
Stroke, Volume 55, Issue Suppl_1 , Page AWP52-AWP52, February 1, 2024. Background:Shortly after AHA/ASA released an updated policy on stroke care systems, COVID-19 disrupted these systems. As a result, telehealth expanded rapidly across Texas.
There were also some unusual circumstances that may have influenced rates of both hospitalization and death, including the COVID-19 pandemic and conflicts involving Russia, Ukraine and Israel, all countries that participated in the trial. ET / 14:45 UTC in Room B203. ET / 13:30 UTC in the Hall B-1 Main Tent.
Moreover, the psychologic burden of fear concerning COVID increased anxiety, especially among healthcare workers, and sapped energy for self-directed learning.” -A. The BoardVitals Cardiology Question Bank has been updated for 2024-2025. What is driving this decrease?
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content